凝介导的瘤T细胞透和免疫逃避,以加强癌症免疫疗法

Guixiang Xu1, Kai Liu2, Xiangwu Chen1

  • 1Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. hewenxiu@sdu.edu.cn.

Nanoscale horizons
|December 12, 2023
PubMed
概括

这项研究引入了一种可注射的水凝,通过改善T细胞透和阻止PD-L1免疫逃避来增强癌症免疫疗法. 这种新的方法提供了一种有效的策略来对抗瘤和转移.